TXG – 10x genomics, inc. (US:NASDAQ)
Stock Stats
News
10x Genomics (TXG) had its price target raised by Citigroup Inc. from $18.00 to $24.00. They now have a "neutral" rating on the stock.
10x Genomics (TXG) was upgraded by William Blair from "market perform" to "outperform".
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC
Form 4 10x Genomics, Inc. For: Mar 02 Filed by: Saxonov Serge
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.